International Chemical Investors Group (ICIG) recently announced an agreement with INEOS and Solvay to acquire certain chlorovinyls assets being divested by INOVYN / INEOS. This agreement, which has been reviewed in the context of the merger control process of both this transaction and the INOVYN JV, has now received approval of the European Commission. Closing of the acquisition of the remedy business by ICIG is anticipated to be August 1st, 2015.




